Skip to main content

Alcohol-related Disorders

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Click City®: AlcoholPhase 21 trial
Active Trials
NCT01847183Completed2,300Est. Jun 2016
Grand Medical
Grand MedicalIsrael - Ramat Gan
1 program
Brief Intervention in Public ClinicN/A1 trial
Active Trials
NCT02388243Completed1,212Est. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsClick City®: Alcohol
Grand MedicalBrief Intervention in Public Clinic

Clinical Trials (2)

Total enrollment: 3,512 patients across 2 trials

NCT01847183Oregon TherapeuticsClick City®: Alcohol

Evaluation of an School-based Alcohol Prevention Program for Middle School Students

Start: Nov 2012Est. completion: Jun 20162,300 patients
Phase 2Completed
NCT02388243Grand MedicalBrief Intervention in Public Clinic

The Computer-based Drug and Alcohol Training Assessment in Kenya

Start: Sep 2014Est. completion: Dec 20151,212 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.